Outcry over REACH from beyond the EU
This article was originally published in Clinica
The contents of the EU's proposed chemicals Regulation, REACH, has caused outrage beyond the EU's borders. Both the authorisation and registration rules have been heavily criticised by a coalition of states, including the US, Brazil and India, who are particularly concerned about the impact of REACH, particularly on SMEs - and especially on manufacturers from developing countries. The coalition, which also includes Japan, Australia, Korea, Malaysia, Singapore, Thailand, Mexico, South Africa, Israel and Chile, is calling on the EU to "use the second reading in Parliament to address the problematic aspects of the proposal".